What kind of company is Afrezza?

What is Afrezza?

Afrezza is a rapid-acting inhaled insulin that is designed for people with diabetes who require insulin to manage their blood sugar levels. It is the only inhaled insulin available on the market and is suitable for use with both type 1 and type 2 diabetes.

About the Company

Afrezza is a product of MannKind Corporation, a biopharmaceutical company that is focused on the development of therapies for diabetes and other diseases. The company was founded in 1991 and is based in Valencia, California.

How does Afrezza work?

Afrezza is delivered through a small inhaler device that disperses the insulin powder into the lungs, where it is absorbed into the bloodstream quickly. This rapid absorption allows for precise dosing and may provide greater flexibility for people with diabetes who need to manage their blood sugar levels.

How to obtain Afrezza

Afrezza is available by prescription only and must be prescribed by a healthcare professional. The company offers assistance programs to help people obtain the medication they need, including a savings card and a patient assistance program.

Conclusion

Overall, Afrezza is a unique and innovative option for people with diabetes who need insulin therapy. Its rapid-acting formula and inhaled delivery system make it a convenient and effective treatment option. MannKind Corporation, the company behind Afrezza, is committed to developing new and innovative therapies to improve the lives of people with diabetes.